Technical analysis of NeurAxis, Inc. (NRXS): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
NeurAxis, Inc. (NRXS) is an American company specializing in neuromodulation therapy devices. Its primary offering is IB-Stim, a percutaneous electrical nerve field stimulation system engineered to alleviate functional abdominal pain associated with irritable bowel syndrome in patients aged 11 to 18. NeurAxis markets its solutions to healthcare providers, predominantly hospitals and clinics.
Price Performance
| 1 month | +10.86% |
| 3 months | -2.94% |
| Year-to-date | +52.86% |
| 1 year | +171.09% |
| 3 years | +86.06% |
52-Week Range
| 52-week High | $9.33 |
| 52-week Low | $2.21 |
| Avg Volume (90d) | 109K |
Technical Indicators
| SMA 50 | $6.43 |
| SMA 200 | $6.07 |
| Beta | 1.89 |
| 30-day Volatility (annualised) | 66.9% |
| Price vs SMA 50 | +7.9% |
| Price vs SMA 200 | +14.4% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $2.72 | |
| 2025-11 | $2.78 | +2.2% |
| 2025-12 | $4.54 | +63.3% |
| 2026-01 | $4.23 | -6.8% |
| 2026-02 | $6.00 | +41.8% |
| 2026-03 | $7.40 | +23.3% |
| 2026-04 | $7.45 | +0.7% |
| 2026-05 | $7.41 | -0.5% |
| 2026-06 | $7.31 | -1.3% |
| 2026-07 | $6.25 | -14.5% |
| 2026-08 | $6.01 | -3.8% |
| 2026-09 | $6.94 | +15.5% |
Price
| Price | $6.94 |
| Market Cap | $87M |
| Exchange | AMEX |
| Country | US |
Valuation Ratios
| Price / Book | 12.38 |
| EV / EBITDA | -8.76 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.04 |
| Current Ratio | 3.04 |